LADENBURG THALMANN FINANCIAL SERVICES INC. - CLEVELAND BIOLABS INC ownership

CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860202. A total of 21 filers reported holding CLEVELAND BIOLABS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of CLEVELAND BIOLABS INC
ValueSharesWeighting
Q4 2019$02650.0%0.00%
Q3 2019$02650.0%0.00%
Q2 2019$02650.0%0.00%
Q1 2019$02650.0%0.00%
Q4 2018$0265
+1225.0%
0.00%
Q3 2018$0200.0%0.00%
Q2 2018$0200.0%0.00%
Q1 2018$0200.0%0.00%
Q4 2017$0
-100.0%
20
-99.4%
0.00%
Q3 2017$12,000
-92.5%
3,570
-90.8%
0.00%
-100.0%
Q2 2017$159,000
+189.1%
38,6800.0%0.00%
+100.0%
Q1 2017$55,000
-11.3%
38,6800.0%0.00%0.0%
Q4 2016$62,000
-18.4%
38,680
-0.4%
0.00%0.0%
Q3 2016$76,000
-7.3%
38,843
+6.0%
0.00%0.0%
Q2 2016$82,000
-34.9%
36,643
-5.7%
0.00%
-50.0%
Q1 2016$126,000
-22.7%
38,843
-0.1%
0.00%
-33.3%
Q4 2015$163,000
+3.2%
38,8880.0%0.00%0.0%
Q3 2015$158,000
+192.6%
38,888
+106.4%
0.00%
+200.0%
Q2 2015$54,000
-53.4%
18,843
-45.1%
0.00%
-50.0%
Q1 2015$116,00034,2930.00%
Other shareholders
CLEVELAND BIOLABS INC shareholders Q3 2016
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 400,080$2,188,0000.31%
Sequoia Financial Advisors, LLC 12,588$69,0000.00%
Cambridge Investment Research Advisors, Inc. 48,725$267,0000.00%
Archer Investment Corp 300$1,641,0000.00%
Renaissance Technologies 98,051$536,0000.00%
VANGUARD GROUP INC 97,535$533,0000.00%
FMR LLC 100$1,0000.00%
US BANCORP \DE\ 1,000$5,0000.00%
BANK OF AMERICA CORP /DE/ 151$1,0000.00%
WELLS FARGO & COMPANY/MN 51$00.00%
View complete list of CLEVELAND BIOLABS INC shareholders